GemVax&KAEL Co.,Ltd. (KOSDAQ:082270)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,370
-160 (-1.52%)
Sep 3, 2026, 3:30 PM KST

GemVax&KAEL Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
85,10481,53162,69272,20975,80460,371
Revenue Growth
24.42%30.05%-13.18%-4.74%25.56%-8.06%
Gross Profit
36,05934,81619,48225,93821,72218,667
Operating Income
8,7043,793-38,337-7,868-3,929-2,450
Net Income
-12,227-11,337-87,219-27,177-19,60412,058
Earnings Per Share
-285.82-274.98-2202.00-691.00-497.32280.00
EPS Growth
-----571.14%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
35,33622,7787,27520,70042,81235,498
Total Debt
76,48360,89373,99014,5437,4408,218
Net Cash (Debt)
-41,147-38,115-66,7156,15735,37227,280
Net Cash Growth
----82.59%29.66%-31.49%
Net Cash Per Share
-961.88-924.51-1684.35156.47897.33633.48

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-919.411,108-28,3693,566-2,955-3,467
Capital Expenditures
-1,729-997.19-3,489-8,461-9,090-6,874
Free Cash Flow
-2,649111.3-31,858-4,895-12,045-10,341
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
42.37%42.70%31.08%35.92%28.66%30.92%
Operating Margin
10.23%4.65%-61.15%-10.90%-5.18%-4.06%
Pretax Margin
-14.56%-14.02%-140.05%-37.87%-25.86%19.97%
Profit Margin
-14.37%-13.91%-139.12%-37.64%-25.86%19.97%
FCF Margin
-3.11%0.14%-50.82%-6.78%-15.89%-17.13%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-----57.60
P/FCF Ratio
-11038.79----
PS Ratio
5.3615.079.377.256.1411.50